Cargando…

Cognitive deficits and white matter abnormalities in never-treated first-episode schizophrenia

Cognitive impairment is viewed as a core symptom of schizophrenia (SCZ), but its pathophysiological mechanism remains unclear. White matter (WM) disruption is considered to be a central abnormality that may contribute to cognitive impairment in SCZ patients. However, few studies have addressed the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mi, Gao, Shan, Zhang, Xiangyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608674/ https://www.ncbi.nlm.nih.gov/pubmed/33139736 http://dx.doi.org/10.1038/s41398-020-01049-0

Ejemplares similares

Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
por: Xiu, Meihong, et al.
Publicado: (2023)

Associations Among Suicidal Ideation, White Matter Integrity and Cognitive Deficit in First-Episode Schizophrenia
por: Long, Yicheng, et al.
Publicado: (2018)

Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia
por: Lang, Xiao-E, et al.
Publicado: (2018)

Cognitive and functional deficits are associated with white matter abnormalities in two independent cohorts of patients with schizophrenia
por: Yamada, Shinichi, et al.
Publicado: (2021)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits
por: Wang, Jingjuan, et al.
Publicado: (2017)

PM475. White matter abnormalities and their associations with clinical symptoms in first episode and drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
por: Olivier, Riaan M., et al.
Publicado: (2017)

Characteristics of White Matter Structural Networks in Chronic Schizophrenia Treated With Clozapine or Risperidone and Those Never Treated
por: Luo, Chunyan, et al.
Publicado: (2020)

White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study
por: Lei, Wei, et al.
Publicado: (2015)

White Matter Alterations in Deficit Schizophrenia
por: Rowland, Laura M., et al.
Publicado: (2008)

Impaired dynamic functional brain properties and their relationship to symptoms in never treated first-episode patients with schizophrenia
por: You, Wanfang, et al.
Publicado: (2022)

Dynamic and Static Cognitive Deficits in Schizophrenia and Bipolar Disorder After the First Episode
por: Zanelli, Jolanta, et al.
Publicado: (2022)

Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients
por: Liu, Nian, et al.
Publicado: (2020)

The correlation between white matter integrity and pragmatic language processing in first episode schizophrenia
por: Pawełczyk, Agnieszka, et al.
Publicado: (2020)

Impaired interactions among white‐matter functional networks in antipsychotic‐naive first‐episode schizophrenia
por: Fan, Yun‐Shuang, et al.
Publicado: (2019)

White-matter hyperintensities in first-episode psychosis
por: Zanetti, Marcus V., et al.
Publicado: (2008)

Anterior Commissural White Matter Fiber Abnormalities in First-Episode Psychosis: A Tractography Study
por: Kikinis, Zora, et al.
Publicado: (2015)

Structural abnormalities of cingulate cortex in patients with first‐episode drug‐naïve schizophrenia comorbid with depressive symptoms
por: Wei, Gao‐Xia, et al.
Publicado: (2020)

The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

TGF-β1 is associated with deficits in cognition and cerebral cortical thickness in first-episode schizophrenia
por: Pan, Shujuan, et al.
Publicado: (2022)

The contribution of the cingulate cortex: treating depressive symptoms in first-episode drug naïve schizophrenia
por: Shen, Haoran, et al.
Publicado: (2023)

White Matter Measures and Cognition in Schizophrenia
por: Erkol, Cemre, et al.
Publicado: (2020)

The stage‐specifically accelerated brain aging in never‐treated first‐episode patients with depression
por: Han, Shaoqiang, et al.
Publicado: (2021)

M68. COGNITIVE IMPAIRMENT IN NEVER-TREATED SCHIZOPHRENIA SPECTRUM INDIVIDUALS
por: Solis-Vivanco, Rodolfo, et al.
Publicado: (2020)

Diffusion Tensor Imaging Findings of White Matter Changes in First Episode Schizophrenia: A Systematic Review
por: Kuswanto, Carissa Nadia, et al.
Publicado: (2012)

48 echo T(2) myelin imaging of white matter in first-episode schizophrenia: Evidence for aberrant myelination
por: Lang, Donna J.M., et al.
Publicado: (2014)

Connectivity-enhanced diffusion analysis reveals white matter density disruptions in first episode and chronic schizophrenia
por: Grazioplene, Rachael G., et al.
Publicado: (2018)

White Matter Integrity in Genetic High-Risk Individuals and First-Episode Schizophrenia Patients: Similarities and Disassociations
por: Zhou, Yifang, et al.
Publicado: (2017)

Corrigendum: The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2021)

Corrigendum: The association between cognitive deficits and clinical characteristic in first-episode drug naïve patients with schizophrenia
por: Peng, Xing-Jie, et al.
Publicado: (2022)

White matter deficits in schizophrenia are global and don’t progress with age
por: Kanaan, Richard A, et al.
Publicado: (2017)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
por: Sun, Qiaoling, et al.
Publicado: (2022)

Differential Cortical Gray Matter Deficits in Adolescent- and Adult-Onset First-Episode Treatment-Naïve Patients with Schizophrenia
por: Zhang, Chengcheng, et al.
Publicado: (2017)

Common gray and white matter abnormalities in schizophrenia and bipolar disorder
por: Lee, Dong-Kyun, et al.
Publicado: (2020)

Advances in schizophrenia research: glycobiology, white matter abnormalities, and their interactions
por: Licinio, Julio, et al.
Publicado: (2020)

PM505. Impaired glucose tolerance, symptoms and cognitive deficits in first-episode drug-naïve patients with schizophrenia
por: Zhang, Xiang-Yang, et al.
Publicado: (2016)

O6.3. PATTERNS OF GRAY MATTER ABNORMALITIES IN PATIENTS WITH FIRST-EPISODE AND TREATMENT-NAïVE SCHIZOPHRENIA
por: Li, Mingli, et al.
Publicado: (2018)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
por: Ding, Yushen, et al.
Publicado: (2023)

White Matter Abnormalities and Animal Models Examining a Putative Role of Altered White Matter in Schizophrenia
por: Xu, Haiyun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q69br1m612ktem0aot8suokshp